Evidence map›Paper›PMID 40565890›Full record

ArticleJournal of clinical medicine2025

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.

Ping Zhou, Mahesh M Mansukhani, Raymond Yeh, Jiesheng Lu, Hongai Xia, Lahari Koganti, Jiuhong Pang, Denis Toskic, Stephanie Scalia, Xun Ma and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ping ZhouThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Mahesh M MansukhaniColumbia University Laboratory of Personalized Genomic Medicine, Department of Pathology & Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA.ORCID 0000-0003-2044-0751
Raymond YehColumbia University Laboratory of Personalized Genomic Medicine, Department of Pathology & Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA.
Jiesheng LuColumbia University Laboratory of Personalized Genomic Medicine, Department of Pathology & Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA.
Hongai XiaColumbia University Laboratory of Personalized Genomic Medicine, Department of Pathology & Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA.
Lahari KogantiColumbia University Laboratory of Personalized Genomic Medicine, Department of Pathology & Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA.
Jiuhong PangColumbia University Laboratory of Personalized Genomic Medicine, Department of Pathology & Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY 10032, USA.
Denis ToskicThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Stephanie ScaliaThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Xun MaThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Lisa X LeeChao Family Comprehensive Cancer Center, University of California, Orange, Irvine, CA 92617, USA.
Sandy W WongHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.
Alfred ChungHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.
Sascha A TuchmanMultiple Myeloma and Amyloidosis Program, Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0003-2109-1573
Terry FogarenThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Nancy Coady LyonsThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Cindy VargaThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.
Suzanne LentzschMultiple Myeloma and Amyloidosis Service, CUIMC, New York, NY 10032, USA.
Raymond L ComenzoThe Tufts Medicine Myeloma and Amyloid Program, Tufts Medical Center, 800 Washington Street, P.O. Box 826, Boston, MA 02111, USA.ORCID 0000-0002-6255-5824

Funding

Screening for AL Amyloidosis in Smoldering Multiple MyelomaR01CA279808 · NCI · TUFTS MEDICAL CENTER · PI Raymond Luke Comenzo · 2024 to 2026
$2.3M
NCI NIH HHS R01 CA279808NIH HHS 1R01CA279808-01A1NIH HHS 1R21AG070502-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AL amyloidosisscreeningsmoldering myeloma

Identifiers

PMID40565890
PMCPMC12193820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.